EXOZYMES INC. — Director's Dealing 2024

Nov 19, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08

Reporting Person: Korman Tyler Paz (Vice President, Research)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	722301	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option for Common Stock	$2.44	2028-01-31	Common Stock (41552)		Direct
Restricted Stock Grant for Common Stock	$2.44	2032-03-25	Common Stock (56456)		Direct
Restricted Stock Grant for Common Stock	$3.32	2033-04-28	Common Stock (22648)		Direct

Footnotes

F1: The shares underlying the grant vest at the rate of 693 shares each month, and are fully vested on 01/31/2026.

F2: The shares underlying the grant vest in full once issued.